The Lancet Respiratory Medicine in conversation with
Ein Podcast von The Lancet Group
156 Folgen
-
Yves Lacasse on long-term oxygen therapy for COPD
Vom: 31.7.2022 -
Rachael Evans on living with long COVID
Vom: 26.7.2022 -
Daniel Munblit and Dale Needham on core outcomes post-COVID-19
Vom: 15.6.2022 -
Daiana Stolz on antibiotic stewardship in pneumonia
Vom: 24.5.2022 -
Ablo Wachinou on sleep disordered breathing in Benin
Vom: 8.4.2022 -
Peter Openshaw and Felicity Liew on corticosteroids in the early in the treatment of COVID
Vom: 7.4.2022 -
Dinh Bui on preterm birth and lung function deficits
Vom: 18.2.2022 -
Ruvim Izĭckson on a joint flu and COVID-19 vaccine
Vom: 31.1.2022 -
Wisia Wedzicha on a vaccine for COPD
Vom: 11.1.2022 -
Eileen Rubin on patient-centered ARDS
Vom: 30.12.2021 -
Daniel Altmann on COVID boosters
Vom: 30.11.2021 -
Michael Kreuter on interstitial lung disease
Vom: 6.9.2021 -
Bairbre McNicholas and Jie Li on awake prone positioning and COVID-19
Vom: 20.8.2021 -
Charles Sprung and authors on end-of-life practices in ICUs globally
Vom: 3.8.2021 -
Christopher Brightling on tezepelumab in patients with moderate-to-severe uncontrolled asthma
Vom: 10.7.2021 -
Paul Verweij on COVID-19 associated aspergillosis
Vom: 26.5.2021 -
Ignacio Rubio on COVID-19 pathophysiology and phenotypes
Vom: 17.5.2021 -
Kiran Shekar on cytokine adsorption and severe COVID-19 pneumonia
Vom: 14.5.2021 -
Fan Chung on chronic cough and long COVID
Vom: 11.5.2021 -
Mepolizumab and the treatment of chronic rhinosinusitis
Vom: 16.4.2021
Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COIVD outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.
